[Federal Register Volume 62, Number 167 (Thursday, August 28, 1997)]
[Notices]
[Pages 45652-45657]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-22900]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention
[Announcement 809]


Grants for Injury Control Research Centers; Notice of 
Availability of Funds for Fiscal Year 1998

Introduction

    The Centers for Disease Control and Prevention (CDC) announces that 
grant applications are being accepted for Injury Control Research 
Centers (ICRCs) for fiscal year (FY) 1998.
    CDC is committed to achieving the health promotion and disease 
prevention objectives of Healthy People 2000, a national activity to 
reduce morbidity and mortality and improve the quality of life. This 
announcement is related to the priority areas of Violent and Abusive 
Behavior and Unintentional Injuries. (To order a copy of Healthy People 
2000, see the Section Where to Obtain Additional Information.)

Authority

    This program is authorized under sections 301, 391, 392, 393, and 
394 of the Public Health Service Act (42 U.S.C. 241, 280b, 280b-1, 
280b-1a, and 280b-2). Program regulations are set forth in 42 CFR part 
52.

Smoke-Free Workplace

    CDC strongly encourages all grant recipients to provide a smoke-
free workplace and to promote the non-use of all tobacco products, and 
Pub. L. 103-227, the Pro-Children Act of 1994, prohibits smoking in 
certain facilities that receive Federal funds in which education, 
library, day care, health care, and early childhood development 
services are provided to children.

Eligible Applicants

    This announcement will provide funding for applicants in regions 
which do not have funded ICRCs and for applicants in regions which have 
funded centers which must recompete for funding.
    Eligible applicants are limited to organizations in Region 1 
(Connecticut, Massachusetts, Maine, New Hampshire, Rhode Island, 
Vermont), Region 2 (New Jersey, New York, Puerto Rico, Virgin Islands), 
Region 3 (Delaware, District of Columbia, Maryland, Pennsylvania, 
Virginia, and West Virginia), Region 5 (Illinois, Indiana, Michigan, 
Minnesota, Ohio, Wisconsin), Region 6 (Louisiana, New Mexico, Oklahoma, 
Texas, Arkansas), and Region 8 (Colorado,

[[Page 45653]]

Montana, North Dakota, South Dakota, Utah, and Wyoming).
    Eligible applicants include all nonprofit and for-profit 
organizations in Regions 1, 2, 3, 5, 6, and 8. Thus, universities, 
colleges, research institutions, hospitals, other public and private 
organizations, State and local health departments, and small, minority 
and/or women-owned businesses are eligible for these grants. Applicants 
from non-academic institutions should provide evidence of a 
collaborative relationship with an academic institution.
    The currently funded centers in Regions 4, 7, 9, and 10 are 
eligible for supplemental funding.

    Note: ICRC grant awards are made to the applicant institution/
organization, not the Principal Investigator.

Availability of Funds

    Approximately $1,500,000 is expected to be available FY 1998 to 
fund at least two re-competing research centers or a combination of 
recompeting and new research center projects, depending on the outcome 
of the review process.
    It is expected that the awards will begin on or around September 1, 
1998, and will be made for a 12 month budget period within a project 
period of up to three years for developing research centers and five 
years for re-competing research centers.
    Funding estimates may vary and are subject to change. Continuation 
awards within the project period will be made on the basis of 
satisfactory progress and the availability of funds.
    Developing research center awards will not exceed $500,000 per year 
(total of direct and indirect costs) with a project period not to 
exceed three years. Depending on availability of funds, re-competing 
research center awards may range from $750,000 to $1,500,000 per year 
(total of direct and indirect costs) with a project period not to 
exceed five years. The range of support provided is dependent upon the 
degree of comprehensiveness of the center in addressing the phases of 
injury control (i.e., Prevention, Acute Care, and Rehabilitation) as 
determined by the Injury Research Grants Review Committee (IRGRC).
    Incremental levels within this range for successfully re-competing 
research centers will be determined as follows:


Base funding (included in figures below)..  Up to $750,000.             
One phase ICRC............................  Up to $1,000,000.           
  (addresses one of the three phases of                                 
   injury control)                                                      
Two phase ICRC............................  Up to $1,250,000.           
  (addresses two of the three phases of                                 
   injury control)                                                      
Comprehensive ICRC........................  Up to $1,500,000.           
  (addresses all three phases of injury                                 
   control)                                                             
                                                                        

    The existing funded centers in Regions 4, 7, 9, and 10 may submit 
proposals for supplemental awards to expand/enhance existing projects, 
to add a new phase(s) to an existing ICRC grant, or to add biomechanics 
project(s) that support one or more phases. The request should not 
exceed $250,000 (direct and indirect cost) per year. Funding is subject 
to program need and the availability of funds.

Use of Funds

Prohibition on use of CDC Funds for Certain Gun Control Activities
    The Departments of Labor, Health and Human Services, and Education, 
and Related Agencies Appropriations Act, 1997 specifies that: None of 
the funds made available for injury prevention and control at the 
Centers for Disease Control and Prevention may be used to advocate or 
promote gun control.
    Anti-Lobbying Act requirements prohibit lobbying Congress with 
appropriated Federal monies. Specifically, this Act prohibits the use 
of Federal funds for direct or indirect communications intended or 
designed to influence a Member of Congress with regard to specific 
Federal legislation. This prohibition includes the funding and 
assistance of public grassroots campaigns intended or designed to 
influence Members of Congress with regard to specific legislation or 
appropriation by Congress. In addition to the restrictions in the Anti-
Lobbying Act, CDC interprets the new language in the CDC's 1997 
Appropriations Act to mean that CDC's funds may not be spent on 
political action or other activities designed to affect the passage of 
specific Federal, State, or local legislation intended to restrict or 
control the purchase or use of firearms.

Background and Definitions

A. Background

    By nearly every measure, injury ranks as one of the nation's most 
pressing health problems. Injuries result from unintended events such 
as car crashes, falls, drownings, fires, and from intentional acts such 
as interpersonal violence and suicide. The annual toll includes the 
loss of more than 150,000 lives. Brain injury, spinal cord injury, and 
burns requiring extensive rehabilitative services number more than 
400,000 annually. Injuries are the country's leading cause of years of 
potential life lost (YPLL) before age 65 (more than 3,600,000 YPLL 
annually in 1994). They are the leading cause of death and disability 
in children and young adults. Older Americans also suffer unduly from 
the severe consequences of injury. Many of the resources of the 
nation's health care system are devoted to attending to victims of 
injury, who occupy one of every eight hospital beds. Injury is also a 
primary cause of visits to physicians; it accounted for 66 million such 
visits in 1992. More than one-fourth of persons who visit emergency 
departments are seeking treatment for injuries. For the United States 
the aggregate lifetime cost of injuries occurring in 1994 was estimated 
to be $224 billion.
    As telling as it is, the litany of injury statistics ignores less 
quantifiable, but equally important concerns--pain and suffering, fear 
of injury among older persons, grief over loss or disablement of loved 
ones, and the inestimable societal loss of unrealized future 
contributions by children and young adults who suffer fatal or 
incapacitating injuries.
    Fortunately, opportunities to understand and prevent injuries and 
reduce their effects are available. To exploit these opportunities will 
require a comprehensive approach to injury control, utilizing many 
disciplines that heretofore have not always been an integral part of 
public health efforts. However, it is not CDC's intention that all 
centers be individually comprehensive, but that the comprehensiveness 
of a priority-driven injury control effort be achieved in the national 
aggregate, building on the individual strengths and geographic balance 
of the various centers.
    Many of these opportunities are discussed in the National Research 
Council and Institute of Medicine report, Injury In America (National 
Academy Press--ISBN 0-309-03545-7). Research priorities are also 
discussed in Injury Prevention: Meeting the

[[Page 45654]]

Challenge (supplement to the American Journal of Preventive Medicine, 
Vol. 5, no. 3, 1989), Cost of Injury (Dorothy P. Rice, Ellen J. 
Mackenzie, and Associates, San Francisco, California: Institute for 
Health and Aging, University of California, and Injury Prevention 
Research Center, The Johns Hopkins University, 1989), Position Papers 
from The Third National Injury Control Conference (Centers for Disease 
Control, Atlanta, Georgia, 1992), and Injury Control in the 1990's: A 
National Plan for Action (Centers for Disease Control and Prevention, 
Atlanta, Georgia, 1993). Information on these reports may be obtained 
from the individuals listed in the section Where to Obtain Additional 
Information.

B. Definitions

    1. Injury is defined as physical damage to an individual that 
occurs over a short period of time as a result of acute exposure to one 
of the forms of physical energy in the environment, or to chemical 
agents, or the acute lack of oxygen. The three phases of injury control 
are defined as prevention, acute care, and rehabilitation. The major 
categories of injury are intentional, unintentional, and occupational. 
Intentional injuries result from interpersonal or self-inflicted 
violence, and include homicide, assaults, suicide and suicide attempts, 
child abuse, spouse abuse, elder abuse, and rape. Unintentional 
injuries include those that result from motor vehicle collisions, 
falls, fires, poisonings, drownings, recreational, and sports-related 
activities. Occupational injuries occur at the worksite and include 
unintentional trauma (for example, work-related motor-vehicle injuries, 
drownings, and electrocutions), and intentional injuries in the 
workplace. Not included in this definition of occupational injuries are 
cumulative trauma disorders, back injuries caused by acute trauma, and 
effects of repeated exposure to chemical or physical agents.
    2. An Injury Control Research Center (ICRC) is defined as a 
scientifically-based organizational unit, generally, but not 
exclusively, established within an academic institution, which reports 
at an organizational level high enough to clearly demonstrate strong 
institutional support for the development of an interdisciplinary 
approach to the injury problem (e.g., dean of a school, university vice 
president, or commissioner of health).
    A comprehensive ICRC is designed to allow the phases of injury 
control (i.e., research in prevention, acute care, and rehabilitation) 
to be addressed by a single organizational unit and managed by an 
experienced research director (dedicated investigator at no less than 
30 percent effort with an anticipated range of 30 percent-50 percent). 
The design of the core should be the basis on which both the research 
and practices of the ICRC are built, further allowing for in-depth 
application of key disciplines (e.g., physicians, epidemiologists, 
engineers, biomechanicists, social and behavioral scientists, 
biostatisticians, public health workers, and others) to the phases of 
injury control. Expertise (defined as: conducting ongoing high quality 
injury research and publication in peer reviewed scientific and 
technical journal(s)) from appropriate disciplinary groups must be 
included so as to address the injury problem phases chosen by the 
applicant.
    A comprehensive ICRC can address all three phases of injury control 
within a single theme. For example, an ICRC with a rehabilitation theme 
can address prevention, acute care, and rehabilitation within the 
overall theme of rehabilitation.
    A less comprehensive ICRC may be designed to allow one or two of 
the phases of the injury problem to be addressed by a single 
organizational unit; in such situations the remaining phase(s) of the 
injury problem may be addressed through collaborative arrangements with 
other institutions or organizations.
    In keeping with CDC's mission as the nation's prevention agency, 
ICRC research is intended to progress from basic research to applied 
research to the development of interventions as described in: Centers 
for Disease Control, A Framework for Assessing the Effectiveness of 
Disease and Injury Prevention. MMWR 1992;41(RR-3).
    While high quality research is to be considered an essential 
ingredient of the ICRC, equally important activities include: 
information gathering and dissemination; the ongoing provision of 
training opportunities to students, researchers, and voluntary, 
community-based, and State and local health department personnel; and 
implementation of projects relating to the development and evaluation 
of injury surveillance or injury prevention programs.

Purpose

    The purposes of this program are:
    A. To support injury prevention and control research on priority 
issues as delineated in: Healthy People 2000; Injury Control in the 
1990's: A National Plan for Action; Injury in America; Injury 
Prevention: Meeting the Challenge; and Cost of Injury: A Report to the 
Congress;
    B. To support ICRCs which represent CDC's largest national 
extramural investment in injury control research and training, 
intervention development, and evaluation;
    C. To integrate collectively, in the context of a national program, 
the disciplines of engineering, epidemiology, medicine, biostatistics, 
public health, law and criminal justice, and behavioral and social 
sciences in order to prevent and control injuries more effectively;
    D. To identify and evaluate current and new interventions for the 
prevention and control of injuries;
    E. To bring the knowledge and expertise of ICRCs to bear on the 
development and improvement of effective public and private sector 
programs for injury prevention and control; and
    F. To facilitate injury control efforts supported by various 
governmental agencies within a geographic region.

Program Requirements

    The following are applicant requirements:
    A. Applicants must demonstrate and apply expertise in at least one 
of the three phases of injury control (prevention, acute care, or 
rehabilitation) as a core component of the center. The second and/or 
third phases do not have to be supported by core funding but may be 
achieved through collaborative arrangements. Comprehensive ICRCs must 
have all three phases supported by core funding.
    B. Applicants must document ongoing injury-related research 
projects or control activities currently supported by other sources of 
funding.
    C. Applicants must provide a director (Principal Investigator) who 
has specific authority and responsibility to carry out the project. The 
director must report to an appropriate institutional official, e.g., 
dean of a school, vice president of a university, or commissioner of 
health. The director must have no less than 30 percent effort devoted 
solely to this project with an anticipated range of 30 to 50 percent.
    D. Applicants must demonstrate experience in successfully 
conducting, evaluating, and publishing injury research and/or 
designing, implementing, and evaluating injury control programs.
    E. Applicants must provide evidence of working relationships with 
outside agencies and other entities which will allow for implementation 
of any proposed intervention activities.
    F. Applicants must provide evidence of involvement of specialists 
or experts in medicine, engineering, epidemiology,

[[Page 45655]]

law and criminal justice, behavioral and social sciences, 
biostatistics, and/or public health as needed to complete the plans of 
the center. These are considered the disciplines and fields for ICRCs. 
An ICRC is encouraged to involve biomechanicists in its research. This, 
again, may be achieved through collaborative relationships as it is no 
longer a requirement that all ICRCs have biomechanical engineering 
expertise.
    G. Applicants must have an established curricula and graduate 
training programs in disciplines relevant to injury control (e.g., 
epidemiology, biomechanics, safety engineering, traffic safety, 
behavioral sciences, or economics).
    H. Applicants must demonstrate the ability to disseminate injury 
control research findings, translate them into interventions, and 
evaluate their effectiveness.
    I. Applicants must have an established relationship, demonstrated 
by letters of agreement, with injury prevention and control programs or 
injury surveillance programs being carried out in the State or region 
in which the ICRC is located. Cooperation with private-sector programs 
is encouraged.
    Applicants should have an established or documented planned 
relationship with organizations or individual leaders in communities 
where injuries occur at high rates, e.g., minority health communities.
    Grant funds will not be made available to support the provision of 
direct care. Studies may be supported which evaluate methods of care 
and rehabilitation for potential reductions in injury effects and 
costs. Studies can be supported which identify the effect on injury 
outcomes and cost of systems for pre-hospital, hospital, and 
rehabilitative care and independent living.
    Eligible applicants may enter into contracts, including consortia 
agreements (as set forth in the PHS Grants Policy Statement, dated 
April 1, 1994), as necessary to meet the requirements of the program 
and strengthen the overall application.

Reporting Requirements

    An original and two copies of the financial status and progress 
reports are due 90 days after the end of each budget period. A final 
financial status and progress reports are due 90 days after the end of 
the project period.

Application Content

    Applications for support of an ICRC should follow the PHS-398 (Rev. 
5/95) application and Errata sheet, and should include the following 
information:
    1. Face page.
    2. Description (abstract) and personnel.
    3. Table of contents.
    4. Detailed budget for the initial budget period: The budget should 
reflect the composite figures for the grant as well as breakdown 
budgets for individual projects within the grant.
    5. Budget for entire proposed project period including budgets 
pertaining to consortium/contractual arrangements.
    6. Biographical sketches of key personnel, consultants, and 
collaborators, beginning with the Principal Investigator and core 
faculty.
    7. Other support: This listing should include all other funds or 
resources pending or currently available. For each grant or contract 
include source of funds, amount of funding (indicate whether pending or 
current), date of funding (initiation and termination), and 
relationship to the proposed program.
    8. Resources and environment.
    9. Research plan including:
    a. A proposed theme for the ICRC's injury control activities. The 
proposed activities should be clearly described in terms of need, 
scientific basis, expected interactions, and anticipated outcomes, 
including the expected effect on injury morbidity and mortality. In 
selecting the theme, applicants should consider the findings in Injury 
In America and the Year 2000 Objectives for the Nation.
    b. A detailed research plan (design and methods) including 
hypothesis and expected outcome, value to field, and specific, 
measurable, and time-framed objectives consistent with the proposed 
theme and activities for each project within the proposed grant.
    c. A detailed evaluation plan which should address outcome and 
cost-effectiveness evaluation as well as formative, efficacy, and 
process evaluation.
    d. A description of the core faculty and its role in implementing 
and evaluating the proposed programs. The applicant should clearly 
specify how disciplines will be integrated to achieve the ICRC's 
objectives.
    e. Charts showing the proposed organizational structure of the ICRC 
and its relationship to the broader institution of which it is a part, 
and, where applicable, to affiliate institutions or collaborating 
organizations. These charts should clearly detail the lines of 
authority as they relate to the center or the project, both 
structurally and operationally. ICRC's should report to an appropriate 
organizational level (e.g. dean of a school, vice president of a 
university, or commissioner of health), demonstrating strong 
institution-wide support of ICRC activity and ensuring oversight of the 
process of interdisciplinary activity.
    f. Documentation of the involved public health agencies and other 
public and private sector entities to be involved in the proposed 
program, including letters that detail commitments of support and a 
clear statement of the role, activities, and participating personnel of 
each agency or entity.
    An applicant organization has the option of having specific salary 
and fringe benefit amounts for individuals omitted from the copies of 
the application which are made available to outside reviewing groups. 
To exercise this option: on the original and five copies of the 
application, the applicant must use asterisks to indicate those 
individuals for whom salaries and fringe benefits are not shown; the 
subtotals must still be shown. In addition, the applicant must submit 
an additional copy of page four of Form PHS-398, completed in full, 
with the asterisks replaced by the salaries and fringe benefits. This 
budget page will be reserved for internal staff use only.

Evaluation Criteria

    Upon receipt, applications will be reviewed by CDC staff for 
completeness and responsiveness as outlined under the previous heading 
Program Requirements. Incomplete applications and applications that are 
not responsive will be returned to the applicant without further 
consideration.
    Applications which are complete and responsive may be subjected to 
a preliminary evaluation (triage) by the Injury Research Grant Review 
Committee (IRGRC) to determine if the application is of sufficient 
technical and scientific merit to warrant further review by the IRGRC; 
CDC will withdraw from further consideration applications judged to be 
noncompetitive and promptly notify the principal investigator/program 
director and the official signing for the applicant organization. Those 
applications judged to be competitive will be further evaluated by a 
dual review process.
    Awards will be made based on priority scores assigned to 
applications by the IRGRC, programmatic priorities and needs determined 
by a secondary review committee (the Advisory Committee for Injury 
Prevention and Control), and the availability of funds.

A. Review by the Injury Research Grants Review Committee

    Peer review of ICRC grant applications will be conducted by the 
IRGRC, which may recommend the

[[Page 45656]]

application for further consideration or not for further consideration. 
As a part of the review process the committee may conduct a site visit 
to the applicant organization for re-competing ICRCs. New applicants 
may be asked to travel to CDC for a meeting with the committee.
    Factors to be considered by IRGRC include:
    1. The specific aims of the application, e.g., the long-term 
objectives and intended accomplishments.
    2. The scientific and technical merit of the overall application, 
including the significance and originality (e.g., new topic, new 
method, new approach in a new population, or advancing understanding of 
the problem) of the proposed research.
    3. The extent to which the evaluation plan will allow for the 
measurement of progress toward the achievement of stated objectives.
    4. Qualifications, adequacy, and appropriateness of personnel to 
accomplish the proposed activities.
    5. The soundness of the proposed budget in terms of adequacy of 
resources and their allocation.
    6. The appropriateness (e.g., responsiveness, quality, and 
quantity) of consultation, technical assistance, and training in 
identifying, implementing, and/or evaluating intervention/control 
measures that will be provided to public and private agencies and 
institutions, with emphasis on State and local health departments, as 
evidenced by letters detailing the nature and extent of this commitment 
and collaboration. Specific letters of support or understanding from 
appropriate governmental bodies must be provided.
    7. Evidence of other public and private financial support.
    8. Details of progress made in the application if the applicant is 
submitting a re-competing application. Documented examples of success 
include: development of pilot projects; completion of high quality 
research projects; publication of findings in peer reviewed scientific 
and technical journals; number of professionals trained; provision of 
consultation and technical assistance; integration of disciplines; 
translation of research into implementation; impact on injury control 
outcomes including legislation, regulation, treatment, and behavior 
modification interventions.

B. Review by CDC Advisory Committee for Injury Prevention and Control 
(ACIPC)

    Factors to be considered by ACIPC include:
    1. The results of the peer review.
    2. The significance of the proposed activities as they relate to 
national program priorities and the achievement of national objectives.
    3. National and programmatic needs and geographic balance.
    4. Overall distribution of the thematic focus of competing 
applications; the nationally comprehensive balance of the program in 
addressing the three phases of injury control (prevention, acute care, 
and rehabilitation); the control of injury among populations who are at 
increased risk, including racial/ethnic minority groups, the elderly 
and children; the major causes of intentional and unintentional injury; 
and the major disciplines of injury control (such as biomechanics and 
epidemiology).
    5. Budgetary considerations, the ACIPC will establish annual 
funding levels as detailed under the heading, Availability of Funds.

C. Applications for Supplemental Funding

    Existing CDC Injury Centers may submit an application for 
supplemental grant awards to support research work or activities. 
Applications should be clearly labeled to denote their status as 
requesting supplemental funding support. These applications will be 
reviewed by the IRGRC and the ACIPC.

D. Continued Funding

    Continuation awards within the project period will be made on the 
basis of the availability of funds and the following criteria:
    1. The accomplishments of the current budget period show that the 
applicant's objectives as prescribed in the yearly workplans are being 
met;
    2. The objectives for the new budget period are realistic, 
specific, and measurable;
    3. The methods described will clearly lead to achievement of these 
objectives;
    4. The evaluation plan allows management to monitor whether the 
methods are effective by having clearly defined process, impact, and 
outcome objectives, and the applicant demonstrates progress in 
implementing the evaluation plan;
    5. The budget request is clearly explained, adequately justified, 
reasonable, and consistent with the intended use of grant funds; and
    6. Progress has been made in developing cooperative and 
collaborative relationships with injury surveillance and control 
programs implemented by State and local governments and private sector 
organizations.

Funding Preference

    Special consideration will be given to re-competing Injury Control 
Research Centers. These centers as established and on-going and serve 
as a resource for Injury Control related issues for their States and 
regions.

Executive Order 12372 Review

    Applications are not subject to the review requirements of 
Executive Order 12372.

Public Health System Reporting Requirements

    This program is not subject to the Public Health System Reporting 
Requirement.

Catalog of Federal Domestic Assistance Number

    The Catalog of Federal Domestic Assistance Number is 93.136.

Other Requirements

A. Human Subjects

    If the proposed project involves research on human subjects, the 
applicant must comply with the Department of Health and Human Services 
Regulations, 45 CFR part 46, regarding the protection of human 
subjects. Assurance must be provided to demonstrate that the project 
will be subject to initial and continuing review by an appropriate 
institutional review committee. The applicant will be responsible for 
providing assurance in accordance with the appropriate guidelines and 
forms provided in the application kit.

B. Animal Subjects

    If the proposed project involves research on animal subjects, the 
applicant must comply with the ``PHS Policy on Humane Care and Use of 
Laboratory Animals by Awardee Institutions.'' An applicant organization 
proposing to use vertebrate animals in PHS-supported activities must 
file an Animal Welfare Assurance with the Office for Protection from 
Research Risks at the National Institutes of Health.

C. Women, Racial and Ethnic Minorities

    It is the policy of the CDC to ensure that women and racial and 
ethnic groups will be included in CDC supported research projects 
involving human subjects, whenever feasible and appropriate. Racial and 
ethnic groups are those defined in OMB Directive No. 15 and include 
American Indian, Alaskan Native, Asian, Pacific Islander, Black and 
Hispanic.
    Applicants shall ensure that women, racial and ethnic minority 
populations

[[Page 45657]]

are appropriately represented in applications for research involving 
human subjects. Where clear and compelling rationale exist that 
inclusion is inappropriate or not feasible, this situation must be 
explained as part of the application.
    In conducting the review of applications for scientific merit, 
review groups will evaluate proposed plans for inclusion of minorities 
and both sexes as part of the scientific assessment and assigned score. 
This policy does not apply to research studies when the investigator 
cannot control the race, ethnicity and/or sex of subjects. Further 
guidance to this policy is contained in the Federal Register, Vol. 60, 
No. 179, Friday, September 15, 1995, pages 47947-47951.

D. Paperwork Reduction Act

    Projects that involve the collection of information from 10 or more 
individuals and funded by this grant program will be subject to review 
by the Office of Management and Budget (OMB) under the Paperwork 
Reduction Act.

Application Submission and Deadlines

A. Preapplication Letter of Intent

    In order to schedule and conduct site visits as part of the formal 
review process, potential applicants are encouraged to submit a 
nonbinding letter of intent to apply. It should be postmarked no later 
than one month prior to the submission deadline of October 5, 1997, for 
the application. The letter should be submitted to the Grants 
Management Specialist whose address is given in Part B of this Section. 
The letter should identify the relevant announcement number for the 
response, name the principal investigator, and specify the injury 
control theme or emphasis of the proposed center (e.g., acute care, 
biomechanics, epidemiology, prevention, intentional injury, or 
rehabilitation). The letter of intent does not influence review or 
funding decisions, but it will enable CDC to plan the review more 
efficiently.

B. Applications

    Applicants should use application Form PHS-398 (OMB No. 0925-0001 
Revised 5/95) and adhere to the ERRATA Instruction Sheet contained in 
the Grant Application Kit. The narrative section for each project 
within an ICRC should not exceed 25 typewritten pages. Refer to the 
instruction in section 1, page 6, of PHS-398 for font type and size. 
Applications not adhering to these specifications may be returned to 
applicant.
    Applicants must submit an original and five copies on or before 
November 5, 1997, to Lisa G. Tamaroff, Grants Management Specialist, 
Grants Management Branch, Procurement and Grants Office, Centers for 
Disease Control and Prevention (CDC), 255 East Paces Ferry Road, NE., 
Room 300, Atlanta, GA 30305.

C. Deadlines

    Applications shall be considered as meeting the deadline above if 
they are either:
    1. Received on or before the deadline date; or
    2. Sent on or before the deadline date and received in time for 
submission to the peer review committee. Applicants should request a 
legibly dated U.S. Postal Service postmark or obtain a legibly dated 
receipt from a commercial carrier or the U.S. Postal Service. Private 
metered postmarks shall not be acceptable as proof of timely mailing.
    Applications which do not meet the criteria in C.1. or C.2. above 
are considered late applications and will be returned to the applicant.

Where to Obtain Additional Information

    To receive additional written information call (404) 332-4561. You 
will be asked to leave your name, address, and telephone number and 
will need to refer to Announcement 809. You will receive a complete 
program description, information on application procedures and 
application forms. Business management technical assistance may be 
obtained from Lisa G. Tamaroff, Grants Management Specialist, Grants 
Management Branch, Procurement and Grants Office, Centers for Disease 
Control and Prevention (CDC), 255 East Paces Ferry Road, NE., Room 321, 
Atlanta, GA 30305, telephone (404) 842-6796 or internet: lgt1.cdc.gov.
    Programmatic technical assistance may be obtained from Tom 
Voglesonger, Program Manager, Injury Control Research Centers, National 
Center for Injury Prevention and Control, Centers for Disease Control 
and Prevention (CDC), 4770 Buford Highway, MS-K58, Atlanta, GA 30341-
3724, telephone (770) 488-4265 or internet address: tdv1.cdc.gov.
    This and other CDC announcements are also available through the CDC 
homepage on the Internet. The address for the CDC homepage is http://
www.cdc.gov.
    CDC will not send application kits by facsimile or express mail 
(even at the request of the applicant).
    Please refer to Announcement 809 when requesting information and 
submitting an application.
    Potential applicants may obtain a copy of Healthy People 2000 (Full 
Report; Stock No. 017-001-00474-0) or Healthy People 2000 (Summary 
Report; Stock No. 017-001-00473-1), referenced in the Introduction, 
through the Superintendent of Documents, Government Printing Office, 
Washington, DC 20402-9325, telephone (202) 512-1800.

    Dated: August 22, 1997.
Joseph R. Carter,
Acting Associate Director for Management and Operations, Centers for 
Disease Control and Prevention (CDC).
[FR Doc. 97-22900 Filed 8-27-97; 8:45 am]
BILLING CODE 4163-18-P